Annual awards program recognizes innovation in bio/pharmaceutical drug development and manufacturing.
Entries are now being accepted for the 2018 CPhI Pharma Awards, which recognize pharma industry innovation across 17 categories of bio/pharmaceutical development, manufacturing, and management, including APIs, excipients, formulations, drug delivery technologies, packaging, patient-centricity, contract services, and business performance.
The awards program, now in its 15th year, honors companies and individuals driving the pharma industry forward through innovations, technologies, and strategies. Winners will be announced at the CPhI Pharma Awards Gala Dinner at the Eurostars Madrid Tower on Oct. 9, 2018, during the CPhI Worldwide trade show in Madrid on Oct. 9–11. CPhI Worldwide, UBM (part of Informa PLC), organizer of CPhI Worldwide and the awards program, announced the 2018 awards categories and deadlines in a July 2, 2018 press statement.
More than 200 entries were submitted in 2017, more than double the number submitted in the previous year. Organizers expect an increase in applications for the Bioprocessing and Manufacturing category as CPhI expands its coverage of bioprocessing technologies with the bioLIVE event, which will be co-located with CPhI Worldwide.
The categories for 2018 are as follows:
Entries must be submitted through an online application form by July 31, 2018. Finalists will be announced on Aug. 28, 2018. The awards presentation will be held at the Eurostars Madrid Tower.
Additional information can be found at the CPhI Pharma Awards site.
CPhI Worldwide and Pharmaceutical Technology are (part of Informa PLC) brands.
Source: CPhI Worldwide
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.